Mortality Risk Stratification Using Cluster Analysis in Patients With Myositis-Associated Interstitial Lung Disease Receiving Initial Triple-Combination Therapy

Mortality Risk Stratification Using Cluster Analysis in Patients With Myositis-Associated Interstitial Lung Disease Receiving Initial Triple-Combination Therapy

ObjectiveTo stratify patients with polymyositis/dermatomyositis-associated interstitial lung disease (ILD) who were initially treated with an intensive regimen consisting of high-dose corticosteroids, a calcineurin inhibitor, and intravenous cyclophosphamide (triple-combo therapy) into subgroups bas...

Full description

Bibliographic Details
Main Authors: Takahisa Gono, Kenichi Masui, Shinji Sato, Masataka Kuwana
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-05-01
Series:Frontiers in Medicine
Subjects:
interstitial lung disease
polymyositis (PM)
dermatomyositis (DM)
anti-MDA5 antibody
cluster analysis
triple-combo therapy
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2022.883699/full

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2022.883699/full

Similar Items